Collection

COVID-19 treatments and clinical trials

DHSC publications relating to COVID-19 treatments and clinical trials.

• From: Department of Health and Social Care
• Published: 6 September 2022
• Last updated: 25 May 2023
  Show all updates

  1. 25 May 2023

     Added 'Higher-risk patients eligible for COVID-19 treatments: independent advisory group report (March 2023)' to the expert advice section.

  2. 31 March 2023

     Renamed and updated document collection to reflect the closure of the Antivirals and Therapeutics Taskforce on 31 March 2023.

  3. 14 December 2022

     Added information under 'Protection' including a link to the Evusheld evaluation.

  4. 6 October 2022

     Added new 'Protection' section containing links to pages on the RAPID C-19 Oversight Group report into Evusheld and letter to patient groups on the decision not to procure Evusheld.

  5. 6 September 2022

     First published.

This collection brings together publications from the Department of Health and Social Care (DHSC) relating to coronavirus (COVID-19) treatments and clinical trials.

For more information, see:

• treatments for COVID-19 on the NHS website
• COVID-19 Therapeutics Clinical Review Panel

Expert advice

• Higher-risk patients eligible for COVID-19 treatments: independent advisory group report (March 2023)
  • 19 September 2023
  • Independent report
• Higher-risk patients eligible for COVID-19 treatments: independent advisory group report
  • 30 May 2022
  • Independent report

Treatments

• Access community-based treatments for coronavirus (COVID-19)
  • 31 March 2023
  • Guidance
• Evaluation of medicines to prevent COVID-19
  • 31 March 2023
  • Guidance

Clinical trials

• Clinical platform trials for coronavirus (COVID-19) treatments
  • 31 March 2023
  • Guidance